APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Drug Discovery Platform Market Analysis and Forecast 2026-2032

5 July 2026187 pages

Choose your research edition.

Industry ResearchAI Drug Discovery Platform Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Discovery Platform Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal AI Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Discovery Platform Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Discovery Platform Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global AI Drug Discovery Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Drug Discovery Platform include Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics and Novadiscovery, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Drug Discovery Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Drug Discovery Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Drug Discovery Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Drug Discovery Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Drug Discovery Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Drug Discovery Platform revenue, projected growth trends, production technology, application and end-user industry.

AI Drug Discovery Platform Segment by Company

Exscientia

Iktos

Delta4

Healx

Innoplexus

BenevolentAI

Evaxion

Genome Biologics

Novadiscovery

Nuritas

CytoReason

Turbine Simulated Cell Technologies

Atomwise

Recursion

Insilico Medicine

Relay Therapeutics

Pfizer

Janssen

AstraZeneca

Beijing Iipharma

AI Drug Discovery Platform Segment by Type

Drug Discovery

Drug Design

AI Drug Discovery Platform Segment by Application

Pharmaceutical Company

Biotech Company

Contract Research Organization

Others

AI Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Drug Discovery Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Drug Discovery Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Discovery Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Discovery Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drug Discovery Major Player Table 3. Drug Design Major Player Table 4. Global AI Drug Discovery Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Company Major Player Table 6. Biotech Company Major Player Table 7. Contract Research Organization Major Player Table 8. Others Major Player Table 9. AI Drug Discovery Platform Industry Trends Table 10. AI Drug Discovery Platform Industry Drivers Table 11. AI Drug Discovery Platform Industry Opportunities and Challenges Table 12. AI Drug Discovery Platform Industry Restraints Table 13. Global AI Drug Discovery Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI Drug Discovery Platform Market Share by Region (2021-2026) Table 16. Global AI Drug Discovery Platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI Drug Discovery Platform Market Share by Region (2027-2032) Table 18. Global AI Drug Discovery Platform Revenue by Players (US$ Million) & (2021-2026) Table 19. Global AI Drug Discovery Platform Revenue Market Share by Players (2021-2026) Table 20. Global AI Drug Discovery Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global AI Drug Discovery Platform Key Players Headquarters & Area Served Table 22. Global AI Drug Discovery Platform Players, Product Type & Application Table 23. Global AI Drug Discovery Platform Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global AI Drug Discovery Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global AI Drug Discovery Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 28. Global AI Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 29. Global AI Drug Discovery Platform Revenue Market Share by Type (2021-2026) Table 30. Global AI Drug Discovery Platform Revenue Market Share by Type (2027-2032) Table 31. Global AI Drug Discovery Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 33. Global AI Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 34. Global AI Drug Discovery Platform Revenue Market Share by Application (2021-2026) Table 35. Global AI Drug Discovery Platform Revenue Market Share by Application (2027-2032) Table 36. Exscientia Company Information Table 37. Exscientia Business Overview Table 38. Exscientia AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Exscientia AI Drug Discovery Platform Product Portfolio Table 40. Exscientia Recent Development Table 41. Iktos Company Information Table 42. Iktos Business Overview Table 43. Iktos AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Iktos AI Drug Discovery Platform Product Portfolio Table 45. Iktos Recent Development Table 46. Delta4 Company Information Table 47. Delta4 Business Overview Table 48. Delta4 AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Delta4 AI Drug Discovery Platform Product Portfolio Table 50. Delta4 Recent Development Table 51. Healx Company Information Table 52. Healx Business Overview Table 53. Healx AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Healx AI Drug Discovery Platform Product Portfolio Table 55. Healx Recent Development Table 56. Innoplexus Company Information Table 57. Innoplexus Business Overview Table 58. Innoplexus AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Innoplexus AI Drug Discovery Platform Product Portfolio Table 60. Innoplexus Recent Development Table 61. BenevolentAI Company Information Table 62. BenevolentAI Business Overview Table 63. BenevolentAI AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. BenevolentAI AI Drug Discovery Platform Product Portfolio Table 65. BenevolentAI Recent Development Table 66. Evaxion Company Information Table 67. Evaxion Business Overview Table 68. Evaxion AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Evaxion AI Drug Discovery Platform Product Portfolio Table 70. Evaxion Recent Development Table 71. Genome Biologics Company Information Table 72. Genome Biologics Business Overview Table 73. Genome Biologics AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Genome Biologics AI Drug Discovery Platform Product Portfolio Table 75. Genome Biologics Recent Development Table 76. Novadiscovery Company Information Table 77. Novadiscovery Business Overview Table 78. Novadiscovery AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Novadiscovery AI Drug Discovery Platform Product Portfolio Table 80. Novadiscovery Recent Development Table 81. Nuritas Company Information Table 82. Nuritas Business Overview Table 83. Nuritas AI Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Nuritas AI Drug Discovery Platform Product Portfolio Table 85. Nuritas Recent Development Table 86. CytoReason Company Information Table 87. CytoReason Business Overview Table 88. CytoReason AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. CytoReason AI Drug Discovery Platform Product Portfolio Table 90. CytoReason Recent Development Table 91. Turbine Simulated Cell Technologies Company Information Table 92. Turbine Simulated Cell Technologies Business Overview Table 93. Turbine Simulated Cell Technologies AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Turbine Simulated Cell Technologies AI Drug Discovery Platform Product Portfolio Table 95. Turbine Simulated Cell Technologies Recent Development Table 96. Atomwise Company Information Table 97. Atomwise Business Overview Table 98. Atomwise AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Atomwise AI Drug Discovery Platform Product Portfolio Table 100. Atomwise Recent Development Table 101. Recursion Company Information Table 102. Recursion Business Overview Table 103. Recursion AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Recursion AI Drug Discovery Platform Product Portfolio Table 105. Recursion Recent Development Table 106. Insilico Medicine Company Information Table 107. Insilico Medicine Business Overview Table 108. Insilico Medicine AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Insilico Medicine AI Drug Discovery Platform Product Portfolio Table 110. Insilico Medicine Recent Development Table 111. Relay Therapeutics Company Information Table 112. Relay Therapeutics Business Overview Table 113. Relay Therapeutics AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Relay Therapeutics AI Drug Discovery Platform Product Portfolio Table 115. Relay Therapeutics Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Pfizer AI Drug Discovery Platform Product Portfolio Table 120. Pfizer Recent Development Table 121. Janssen Company Information Table 122. Janssen Business Overview Table 123. Janssen AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Janssen AI Drug Discovery Platform Product Portfolio Table 125. Janssen Recent Development Table 126. AstraZeneca Company Information Table 127. AstraZeneca Business Overview Table 128. AstraZeneca AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. AstraZeneca AI Drug Discovery Platform Product Portfolio Table 130. AstraZeneca Recent Development Table 131. Beijing Iipharma Company Information Table 132. Beijing Iipharma Business Overview Table 133. Beijing Iipharma AI Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Beijing Iipharma AI Drug Discovery Platform Product Portfolio Table 135. Beijing Iipharma Recent Development Table 136. North America AI Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 137. North America AI Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 138. North America AI Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 139. North America AI Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 140. North America AI Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America AI Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 142. North America AI Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 143. Europe AI Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 144. Europe AI Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 145. Europe AI Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe AI Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe AI Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe AI Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 149. Europe AI Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 150. China AI Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 151. China AI Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 152. China AI Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 153. China AI Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia AI Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 155. Asia AI Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 156. Asia AI Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia AI Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia AI Drug Discovery Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia AI Drug Discovery Platform Revenue by Region (US$ Million) & (2021-2026) Table 160. Asia AI Drug Discovery Platform Revenue by Region (US$ Million) & (2027-2032) Table 161. SAMEA AI Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA AI Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA AI Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA AI Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA AI Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA AI Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 167. SAMEA AI Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. AI Drug Discovery Platform Image Figure 2. Global AI Drug Discovery Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Discovery Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drug Discovery Image Figure 5. Drug Design Image Figure 6. Global AI Drug Discovery Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI Drug Discovery Platform Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Company Image Figure 9. Biotech Company Image Figure 10. Contract Research Organization Image Figure 11. Others Image Figure 12. Global AI Drug Discovery Platform Market Size (US$ Million) & (2021-2032) Figure 13. Global AI Drug Discovery Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global AI Drug Discovery Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global AI Drug Discovery Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global AI Drug Discovery Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Drug Discovery Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global AI Drug Discovery Platform Revenue Market Share by Type (2021-2032) Figure 20. Global AI Drug Discovery Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI Drug Discovery Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global AI Drug Discovery Platform Revenue Market Share by Application (2021-2032) Figure 23. North America AI Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America AI Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 25. North America AI Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 26. North America AI Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 27. United States AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe AI Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe AI Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 32. Europe AI Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 33. Europe AI Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 34. Germany AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China AI Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China AI Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 44. China AI Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 45. Asia AI Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia AI Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 47. Asia AI Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 48. Asia AI Drug Discovery Platform Revenue Share by Region (2021-2032) Figure 49. Japan AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA AI Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA AI Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 57. SAMEA AI Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 58. SAMEA AI Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 59. Brazil AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt AI Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Discovery
  • Drug Design
Applications
  • Pharmaceutical Company
  • Biotech Company
  • Contract Research Organization
  • Others
Companies covered
  • Exscientia
  • Iktos
  • Delta4
  • Healx
  • Innoplexus
  • BenevolentAI
  • Evaxion
  • Genome Biologics
  • Novadiscovery
  • Nuritas
  • CytoReason
  • Turbine Simulated Cell Technologies
  • Atomwise
  • Recursion
  • Insilico Medicine
  • Relay Therapeutics
  • Pfizer
  • Janssen
  • AstraZeneca
  • Beijing Iipharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Drug Discovery Platform Market by Type
  3. 1.2.1 Global AI Drug Discovery Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drug Discovery
  5. 1.2.3 Drug Design
  6. 1.3 AI Drug Discovery Platform Market by Application
  7. 1.3.1 Global AI Drug Discovery Platform Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Company
  9. 1.3.3 Biotech Company
  10. 1.3.4 Contract Research Organization
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 AI Drug Discovery Platform Market Dynamics
  1. 2.1 AI Drug Discovery Platform Industry Trends
  2. 2.2 AI Drug Discovery Platform Industry Drivers
  3. 2.3 AI Drug Discovery Platform Industry Opportunities and Challenges
  4. 2.4 AI Drug Discovery Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Drug Discovery Platform Market Perspective (2021-2032)
  2. 3.2 Global AI Drug Discovery Platform Growth Trends by Region
  3. 3.2.1 Global AI Drug Discovery Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Drug Discovery Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Drug Discovery Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Drug Discovery Platform Revenue by Players
  2. 4.1.1 Global AI Drug Discovery Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Drug Discovery Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Drug Discovery Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Drug Discovery Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Drug Discovery Platform Key Players Headquarters & Area Served
  7. 4.4 Global AI Drug Discovery Platform Players, Product Type & Application
  8. 4.5 Global AI Drug Discovery Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Drug Discovery Platform Market CR5 and HHI
  11. 4.6.3 2025 AI Drug Discovery Platform Tier 1, Tier 2, and Tier 3
5 AI Drug Discovery Platform Market Size by Type
  1. 5.1 Global AI Drug Discovery Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Discovery Platform Revenue by Type (2021-2032)
  3. 5.3 Global AI Drug Discovery Platform Revenue Market Share by Type (2021-2032)
6 AI Drug Discovery Platform Market Size by Application
  1. 6.1 Global AI Drug Discovery Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Drug Discovery Platform Revenue by Application (2021-2032)
  3. 6.3 Global AI Drug Discovery Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Exscientia
  2. 7.1.1 Exscientia Company Information
  3. 7.1.2 Exscientia Business Overview
  4. 7.1.3 Exscientia AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Exscientia AI Drug Discovery Platform Product Portfolio
  6. 7.1.5 Exscientia Recent Developments
  7. 7.2 Iktos
  8. 7.2.1 Iktos Company Information
  9. 7.2.2 Iktos Business Overview
  10. 7.2.3 Iktos AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Iktos AI Drug Discovery Platform Product Portfolio
  12. 7.2.5 Iktos Recent Developments
  13. 7.3 Delta4
  14. 7.3.1 Delta4 Company Information
  15. 7.3.2 Delta4 Business Overview
  16. 7.3.3 Delta4 AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Delta4 AI Drug Discovery Platform Product Portfolio
  18. 7.3.5 Delta4 Recent Developments
  19. 7.4 Healx
  20. 7.4.1 Healx Company Information
  21. 7.4.2 Healx Business Overview
  22. 7.4.3 Healx AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Healx AI Drug Discovery Platform Product Portfolio
  24. 7.4.5 Healx Recent Developments
  25. 7.5 Innoplexus
  26. 7.5.1 Innoplexus Company Information
  27. 7.5.2 Innoplexus Business Overview
  28. 7.5.3 Innoplexus AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Innoplexus AI Drug Discovery Platform Product Portfolio
  30. 7.5.5 Innoplexus Recent Developments
  31. 7.6 BenevolentAI
  32. 7.6.1 BenevolentAI Company Information
  33. 7.6.2 BenevolentAI Business Overview
  34. 7.6.3 BenevolentAI AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BenevolentAI AI Drug Discovery Platform Product Portfolio
  36. 7.6.5 BenevolentAI Recent Developments
  37. 7.7 Evaxion
  38. 7.7.1 Evaxion Company Information
  39. 7.7.2 Evaxion Business Overview
  40. 7.7.3 Evaxion AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Evaxion AI Drug Discovery Platform Product Portfolio
  42. 7.7.5 Evaxion Recent Developments
  43. 7.8 Genome Biologics
  44. 7.8.1 Genome Biologics Company Information
  45. 7.8.2 Genome Biologics Business Overview
  46. 7.8.3 Genome Biologics AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Genome Biologics AI Drug Discovery Platform Product Portfolio
  48. 7.8.5 Genome Biologics Recent Developments
  49. 7.9 Novadiscovery
  50. 7.9.1 Novadiscovery Company Information
  51. 7.9.2 Novadiscovery Business Overview
  52. 7.9.3 Novadiscovery AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Novadiscovery AI Drug Discovery Platform Product Portfolio
  54. 7.9.5 Novadiscovery Recent Developments
  55. 7.10 Nuritas
  56. 7.10.1 Nuritas Company Information
  57. 7.10.2 Nuritas Business Overview
  58. 7.10.3 Nuritas AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Nuritas AI Drug Discovery Platform Product Portfolio
  60. 7.10.5 Nuritas Recent Developments
  61. 7.11 CytoReason
  62. 7.11.1 CytoReason Company Information
  63. 7.11.2 CytoReason Business Overview
  64. 7.11.3 CytoReason AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 CytoReason AI Drug Discovery Platform Product Portfolio
  66. 7.11.5 CytoReason Recent Developments
  67. 7.12 Turbine Simulated Cell Technologies
  68. 7.12.1 Turbine Simulated Cell Technologies Company Information
  69. 7.12.2 Turbine Simulated Cell Technologies Business Overview
  70. 7.12.3 Turbine Simulated Cell Technologies AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Turbine Simulated Cell Technologies AI Drug Discovery Platform Product Portfolio
  72. 7.12.5 Turbine Simulated Cell Technologies Recent Developments
  73. 7.13 Atomwise
  74. 7.13.1 Atomwise Company Information
  75. 7.13.2 Atomwise Business Overview
  76. 7.13.3 Atomwise AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Atomwise AI Drug Discovery Platform Product Portfolio
  78. 7.13.5 Atomwise Recent Developments
  79. 7.14 Recursion
  80. 7.14.1 Recursion Company Information
  81. 7.14.2 Recursion Business Overview
  82. 7.14.3 Recursion AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Recursion AI Drug Discovery Platform Product Portfolio
  84. 7.14.5 Recursion Recent Developments
  85. 7.15 Insilico Medicine
  86. 7.15.1 Insilico Medicine Company Information
  87. 7.15.2 Insilico Medicine Business Overview
  88. 7.15.3 Insilico Medicine AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Insilico Medicine AI Drug Discovery Platform Product Portfolio
  90. 7.15.5 Insilico Medicine Recent Developments
  91. 7.16 Relay Therapeutics
  92. 7.16.1 Relay Therapeutics Company Information
  93. 7.16.2 Relay Therapeutics Business Overview
  94. 7.16.3 Relay Therapeutics AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Relay Therapeutics AI Drug Discovery Platform Product Portfolio
  96. 7.16.5 Relay Therapeutics Recent Developments
  97. 7.17 Pfizer
  98. 7.17.1 Pfizer Company Information
  99. 7.17.2 Pfizer Business Overview
  100. 7.17.3 Pfizer AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Pfizer AI Drug Discovery Platform Product Portfolio
  102. 7.17.5 Pfizer Recent Developments
  103. 7.18 Janssen
  104. 7.18.1 Janssen Company Information
  105. 7.18.2 Janssen Business Overview
  106. 7.18.3 Janssen AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Janssen AI Drug Discovery Platform Product Portfolio
  108. 7.18.5 Janssen Recent Developments
  109. 7.19 AstraZeneca
  110. 7.19.1 AstraZeneca Company Information
  111. 7.19.2 AstraZeneca Business Overview
  112. 7.19.3 AstraZeneca AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  113. 7.19.4 AstraZeneca AI Drug Discovery Platform Product Portfolio
  114. 7.19.5 AstraZeneca Recent Developments
  115. 7.20 Beijing Iipharma
  116. 7.20.1 Beijing Iipharma Company Information
  117. 7.20.2 Beijing Iipharma Business Overview
  118. 7.20.3 Beijing Iipharma AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Beijing Iipharma AI Drug Discovery Platform Product Portfolio
  120. 7.20.5 Beijing Iipharma Recent Developments
8 North America
  1. 8.1 North America AI Drug Discovery Platform Revenue (2021-2032)
  2. 8.2 North America AI Drug Discovery Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Drug Discovery Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Drug Discovery Platform Revenue by Type (2027-2032)
  5. 8.3 North America AI Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Drug Discovery Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Drug Discovery Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Drug Discovery Platform Revenue by Application (2027-2032)
  9. 8.5 North America AI Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Drug Discovery Platform Revenue by Country
  11. 8.6.1 North America AI Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Drug Discovery Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Drug Discovery Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Drug Discovery Platform Revenue (2021-2032)
  2. 9.2 Europe AI Drug Discovery Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Drug Discovery Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Drug Discovery Platform Revenue by Type (2027-2032)
  5. 9.3 Europe AI Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Drug Discovery Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Drug Discovery Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Drug Discovery Platform Revenue by Application (2027-2032)
  9. 9.5 Europe AI Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Drug Discovery Platform Revenue by Country
  11. 9.6.1 Europe AI Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Drug Discovery Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Drug Discovery Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Drug Discovery Platform Revenue (2021-2032)
  2. 10.2 China AI Drug Discovery Platform Revenue by Type (2021-2032)
  3. 10.2.1 China AI Drug Discovery Platform Revenue by Type (2021-2026)
  4. 10.2.2 China AI Drug Discovery Platform Revenue by Type (2027-2032)
  5. 10.3 China AI Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 10.4 China AI Drug Discovery Platform Revenue by Application (2021-2032)
  7. 10.4.1 China AI Drug Discovery Platform Revenue by Application (2021-2026)
  8. 10.4.2 China AI Drug Discovery Platform Revenue by Application (2027-2032)
  9. 10.5 China AI Drug Discovery Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Drug Discovery Platform Revenue (2021-2032)
  2. 11.2 Asia AI Drug Discovery Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Drug Discovery Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Drug Discovery Platform Revenue by Type (2027-2032)
  5. 11.3 Asia AI Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Drug Discovery Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Drug Discovery Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Drug Discovery Platform Revenue by Application (2027-2032)
  9. 11.5 Asia AI Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Drug Discovery Platform Revenue by Country
  11. 11.6.1 Asia AI Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Drug Discovery Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Drug Discovery Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Drug Discovery Platform Revenue (2021-2032)
  2. 12.2 SAMEA AI Drug Discovery Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Drug Discovery Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Drug Discovery Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Drug Discovery Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Drug Discovery Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Drug Discovery Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Drug Discovery Platform Revenue by Country
  11. 12.6.1 SAMEA AI Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Drug Discovery Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Drug Discovery Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst